Literature DB >> 18450581

Spike timing-dependent long-term potentiation in ventral tegmental area dopamine cells requires PKC.

Percy Luu1, Robert C Malenka.   

Abstract

Long-term potentiation (LTP) of excitatory synapses on ventral tegmental area (VTA) dopamine (DA) cells is thought to play an important role in mediating some of the behavioral effects of drugs of abuse yet little is known about its underlying mechanisms. We find that spike timing-dependent LTP (STD LTP) in VTA DA cells is absent in slices prepared from mice previously administered cocaine, suggesting that cocaine-induced LTP and STD LTP share underlying mechanisms. This form of STD LTP is dependent on NMDA receptor (NMDAR) activation and a rise in postsynaptic calcium but surprisingly was not affected by an inhibitor of calcium/calmodulin-dependent protein kinase II (CaMKII). It was blocked by antagonists of conventional isoforms of PKC, whereas activation of protein kinase C (PKC) using a phorbol ester enhanced synaptic strength. These results suggest that NMDAR-mediated activation of PKC, but not CaMKII, is a critical trigger for LTP in VTA DA cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450581      PMCID: PMC2493500          DOI: 10.1152/jn.01384.2007

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  33 in total

1.  Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons.

Authors:  Daniel Saal; Yan Dong; Antonello Bonci; Robert C Malenka
Journal:  Neuron       Date:  2003-02-20       Impact factor: 17.173

2.  Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors.

Authors:  Per Jesper Sjöström; Gina G Turrigiano; Sacha B Nelson
Journal:  Neuron       Date:  2003-08-14       Impact factor: 17.173

Review 3.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

4.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

Review 5.  Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways.

Authors:  Marina E Wolf
Journal:  Mol Interv       Date:  2002-06

Review 6.  Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse.

Authors:  Julie A Kauer
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

Review 7.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

Review 8.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

9.  Potentiation of synaptic transmission in the hippocampus by phorbol esters.

Authors:  R C Malenka; D V Madison; R A Nicoll
Journal:  Nature       Date:  1986 May 8-14       Impact factor: 49.962

10.  Phorbol esters enhance transmitter release in rat hippocampal slices.

Authors:  R C Malenka; G S Ayoub; R A Nicoll
Journal:  Brain Res       Date:  1987-02-10       Impact factor: 3.252

View more
  23 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  PKCbeta co-localizes with the dopamine transporter in mesencephalic neurons.

Authors:  Heather A O'Malley; Yanghae Park; Lori L Isom; Margaret E Gnegy
Journal:  Neurosci Lett       Date:  2010-08-09       Impact factor: 3.046

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects.

Authors:  Bin Pan; Peng Zhong; Dalong Sun; Qing-song Liu
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

Review 5.  Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.

Authors:  Billy T Chen; F Woodward Hopf; Antonello Bonci
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  Dopamine D1 and D5 receptors modulate spike timing-dependent plasticity at medial perforant path to dentate granule cell synapses.

Authors:  Kechun Yang; John A Dani
Journal:  J Neurosci       Date:  2014-11-26       Impact factor: 6.167

Review 7.  Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.

Authors:  H Morikawa; C A Paladini
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

8.  Cocaine self-administration abolishes endocannabinoid-mediated long-term depression of glutamatergic synapses in the ventral tegmental area.

Authors:  Ruixiang Wang; Kathryn A Hausknecht; Amy M Gancarz-Kausch; Saida Oubraim; Roh-Yu Shen; Samir Haj-Dahmane
Journal:  Eur J Neurosci       Date:  2020-09-30       Impact factor: 3.386

Review 9.  Plasticity of addiction: a mesolimbic dopamine short-circuit?

Authors:  Jason L Niehaus; Nelson D Cruz-Bermudez; Julie A Kauer
Journal:  Am J Addict       Date:  2009 Jul-Aug

10.  D(2) receptors receive paracrine neurotransmission and are consistently targeted to a subset of synaptic structures in an identified neuron of the crustacean stomatogastric nervous system.

Authors:  Max F Oginsky; Edmund W Rodgers; Merry C Clark; Robert Simmons; Wulf-Dieter C Krenz; Deborah J Baro
Journal:  J Comp Neurol       Date:  2010-02-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.